Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Perhaps they are no longer supporters of Oxford United FC 😂
Essential: ability to perform calculations on extremely large numbers 😀
Drac, I think Redmile and Vulpes would have something to say about a cheap buyout.
"Derisory offer" is the phrase that springs to mind
It looks like myself and Bermuda were also thinking along the same lines :-)
I was thinking along the same lines Johnny.
We will probably never know what the current situation is.
The other point I would make about SC129 is that Scancell intend to trial it as a bi-specific antibody once funds permit.
That does leave other options available to pharmas e.g. Car-T or attaching an ADC as two examples.
I think we are in the middle of a Suzy Q and A session
He has a successful lab to run 😂
I seem to remember that Lindy mentioned BMS in connection with Glycans, but I think she also said that their work did not show the same promise as Scancell's work (or words to that effect).
That was at one of the recent AGMs.
Of course it matters
1) TRX
2) Ambrose
3) Sanderson
Spot the pattern
Sorry first link should be:
https://find-and-update.company-information.service.gov.uk/company/08203248
Click on "people"
Https://find-and-update.company-information.service.gov.uk/company/08203248
Yes, I see what you mean.
"This company investing used to be called Beaufort Securities. They were as bent as a two bob note. Something dodgy if you ask me!"
I think the connection is that the boss of Sanderson was also the boss of Beaufort Securities.
Beaufort Securities crashed in spectacular fashion
https://www.ft.com/content/24db2600-22ff-11e8-add1-0e8958b189ea
It's good to see Scancell scientists other than Lindy taking part in conferences.
Let's hope it's a sign that Lindy is too busy talking to parties who are interested in doing deals 😀
A lot of credit due Lindy's success with Glycans mAbs.
PM is leader of the "Deal by the end of March" party.
We await the reasoning behind this deadline.
"crowdfunding" page coming soon 😂
Dalester, let's hope that there is more than just one Godot on the way 😂
The question is how much is a product worth if :
a) any clinical or pre-clinical results have not been peer reviewed?
b) pharma have shown no interest in the product so far?
c) the product has not been showcased at conferences?
d) there has been little or nothing published in scientific journals about the product?
I'm not sure that the latest Iceman incarnation is a blithering idiot.
He may be a clever pumper and dumper just sounding out sentiment 😂
Maybe the £ was a typo as well 🤣